Skip the main content if you do not want to read it as the next section.
Skip the location trail if you do not want to read it as the next section.
Location trail
HEALTH PROFESSIONALS > TREATMENT GUIDELINES > SPECIFIC CANCERS > PROSTATEUK treatment guidelines - Prostate cancer
- Advice on the development of low dose rate (permanent seed implant) brachytherapy services for localised prostate cancer in England - November 2006
- Guidance on Laparoscopic radical prostatectomy - NICE November 2006
- Docetaxel for the treatment of hormone-refractory metastatic prostate cancer - NICE June 2006
- High dose rate brachytherapy for prostate cancer - NICE May 2006
- Cryotherapy as a primary treatment for prostate cancer - NICE November 2005
- Low dose rate brachytherapy for localised prostate cancer: Guidance - July 2005
- Cryotherapy for recurrent prostate cancer: Guidance - May 2005
- High-intensity focused ultrasound for prostate cancer: Guidance - March 2005
- Guidance on Cancer Services: Improving Outcomes in Urological Cancers, The Manual - NICE 2002
Advice on the development of low dose rate (permanent seed implant) brachytherapy services for localised prostate cancer in England - November 2006
Produced by: Department of Health (DH) – Cancer Services Collaborative.
Purpose: Aims to provide advice to strategic health authorities (SHAs), cancer networks, primary care trusts (PCTs) and NHS Trusts in England that are developing, providing or commissioning low dose rate prostate brachytherapy services.
Can be obtained from: From the DH website www.dh.gov.uk
Guidance on Laparoscopic radical prostatectomy - NICE November 2006
Produced by: National Institute for Clinical Excellence (NICE), Interventional Procedures Guidance No. 16.
Purpose: Current evidence for the NHS on the safety and efficacy of laparoscopic radical prostatectomy.
Can be obtained from: The full guidance, interventional procedure overview and public information leaflet are available to download from the NICE website.
Link to website: www.nice.org.uk/guidance/IPG193
Docetaxel for the treatment of hormone-refractory metastatic prostate cancer - NICE June 2006
Produced by: National Institute for Health and Clinical Excellence (NICE), June 2006.
Purpose: Guidance for the NHS about when docetaxel is recommended as a possible treatment for men with hormone-refractory metastatic prostate cancer.
Can be obtained from: The full guidance, quick reference guide and public information leaflet are available to download from the website.
Link to website: www.nice.org.uk/guidance/TA101
High dose rate brachytherapy for prostate cancer - NICE May 2006
Produced by: NICE - National Institute for Health and Clinical Excellence. Interventional procedure guidance 174 (IPG174).
Purpose: Full guidance for the NHS about the use of this procedure for prostate cancer. Describes the procedure and reviews its indications, safety and efficacy.
Can be obtained from: The full guidance, interventional procedure overview and public information leaflet are available to download from the website.
Link to website: www.nice.org.uk/guidance/IPG174
Cryotherapy as a primary treatment for prostate cancer - NICE November 2005
Produced by: NICE- National Institute for Health and Clinical Excellence. Interventional procedure guidance 145 (IPG145).
Purpose: Full guidance to the NHS in England, Wales, Scotland and Northern Ireland on the use of cryotherapy as a primary treatment for prostate cancer. Describes the procedure and reviews its indications, safety and efficacy.
Can be obtained from: The full guidance, interventional procedure overview and public information leaflet are available to download from the website.
Link to website: www.nice.org.uk/guidance/IPG145
Low dose rate brachytherapy for localised prostate cancer: Guidance - July 2005
Produced by: National Institute for Health and Clinical Excellence (NICE). Interventional procedure guidance 132 (IPG132).
Purpose: Full guidance to the NHS on LDR brachytherapy for localised prostate cancer. Describes the procedure and reviews its indications, safety and efficacy.
Can be obtained from: The full guidance, background research material, and public information leaflet are available to download from the NICE website.
Link to website: www.nice.org.uk/guidance/IPG132
Cryotherapy for recurrent prostate cancer: Guidance - May 2005
Produced by: National Institute for Health and Clinical Excellence (NICE). Interventional procedure guidance 119 (IPG119).
Purpose: Full guidance to the NHS on cryotherapy for recurrent prostate cancer. Describes the procedure and reviews its indications, safety and efficacy.
Can be obtained from: The full guidance, background research material, and public information leaflet are available to download from the NICE website.
Link to website: www.nice.org.uk/guidance/IPG119
High-intensity focused ultrasound for prostate cancer: Guidance - March 2005
Produced by: National Institute for Health and Clinical Excellence (NICE). Interventional procedure guidance 118 (IPG118).
Purpose: Full guidance to the NHS on HIFU for prostate cancer. Describes the procedure and reviews its indications, safety and efficacy.
Can be obtained from: The full guidance, background research material, and public information leaflet are available to download from the NICE website.
Link to website: www.nice.org.uk/guidance/IPG118
Guidance on Cancer Services: Improving Outcomes in Urological Cancers, The Manual - NICE 2002
Produced by: National Institute for Clinical Excellence (NICE), September 2002.
Purpose: This document provides recommendations about the organisation and delivery of urological cancer services.
Can be obtained from: The full manual, background research material, and public information leaflet are available to download from the NICE website.
Link to website: www.nice.org.uk/guidance/csguc
Content last reviewed: 11 July 2007
Page last modified: 14 January 2009
Page last modified: 14 January 2009